Molecular imaging in cardiovascular disease: Which methods, which diseases?

Area of Science:

• Cardiovascular Imaging
• Molecular Biology
• Medical Diagnostics

Background:

• Non-invasive cardiovascular imaging techniques are evolving to assess molecular changes in vivo.
• Evaluating tissue molecular or cellular phenotype can improve diagnostic capabilities and clinical care.
• These techniques offer earlier disease detection and personalized therapeutic guidance.

Purpose of the Study:

• To review the current status of molecular imaging in cardiovascular medicine.
• To highlight clinical and research applications of molecular imaging.
• To focus on specific target areas such as atherosclerosis, ischemia, and remodeling.

Main Methods:

• Development of novel targeted contrast agents with disease-specific kinetic properties.
• Utilizing molecular imaging for in vivo assessment of molecular and cellular phenotypes.
• Focus on non-invasive imaging modalities for cardiovascular applications.

Main Results:

• Molecular imaging holds potential for earlier disease detection and more effective therapy guidance.
• It can characterize pathophysiology and serve as surrogate endpoints in research.
• Targeted contrast agents are a primary approach for molecular imaging.

Conclusions:

• Molecular imaging is poised to significantly benefit cardiovascular diagnostics and research.
• Applications include assessing atherosclerotic disease, tissue ischemia, and cardiac/vascular remodeling.
• The field offers enhanced clinical care through improved diagnostic and therapeutic strategies.